StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$0.25−0.03 (-11.87%)

Close on Nov 13, 2026Market cap $3.86MP/E –Yield –

Traws Pharma total assets

Total assets on the balance sheet at the end of each period.

Traws Pharma's total assets was $11.47M at Jun 30, 2026. For fiscal 2025 it was $10.62M, down 57.5% from the year before. Over ten years it grew -7.6% a year on average. The highest annual figure on record is $105.15M in fiscal 2013.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.62M-57.5%
FY2024Dec 31, 2024$24.96M+10.0%
FY2023Dec 31, 2023$22.68M-42.4%
FY2022Dec 31, 2022$39.37M-29.0%
FY2021Dec 31, 2021$55.48M+177.6%
FY2020Dec 31, 2020$19.99M-15.6%
FY2019Dec 31, 2019$23.67M+32.1%
FY2018Dec 31, 2018$17.92M+260.0%
FY2017Dec 31, 2017$4.98M-78.6%
FY2016Dec 31, 2016$23.23M-0.9%
FY2015Dec 31, 2015$23.45M-50.5%
FY2014Dec 31, 2014$47.34M-55.0%
FY2013Dec 31, 2013$105.15M+25.4%
FY2012Dec 31, 2012$83.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.47M-26.6%
Q1 FY2026Mar 31, 2026$8.16M-57.2%
Q4 FY2025Dec 31, 2025$10.62M-57.5%
Q3 FY2025Sep 30, 2025$12.44M+39.2%
Q2 FY2025Jun 30, 2025$15.62M-16.4%
Q1 FY2025Mar 31, 2025$19.06M+4.9%
Q4 FY2024Dec 31, 2024$24.96M+10.0%
Q3 FY2024Sep 30, 2024$8.94M-67.0%
Q2 FY2024Jun 30, 2024$18.69M-38.7%
Q1 FY2024Mar 31, 2024$18.17M-48.2%
Q4 FY2023Dec 31, 2023$22.68M-42.4%
Q3 FY2023Sep 30, 2023$27.04M-38.2%
Q2 FY2023Jun 30, 2023$30.47M-36.6%
Q1 FY2023Mar 31, 2023$35.06M-31.8%
Q4 FY2022Dec 31, 2022$39.37M-29.0%
Q3 FY2022Sep 30, 2022$43.78M-27.0%
Q2 FY2022Jun 30, 2022$48.07M+8.3%
Q1 FY2022Mar 31, 2022$51.42M+5.3%
Q4 FY2021Dec 31, 2021$55.48M+177.6%
Q3 FY2021Sep 30, 2021$59.99M+138.0%
Q2 FY2021Jun 30, 2021$44.38M+57.4%
Q1 FY2021Mar 31, 2021$48.85M+52.3%
Q4 FY2020Dec 31, 2020$19.99M-15.6%
Q3 FY2020Sep 30, 2020$25.21M+319.8%
Q2 FY2020Jun 30, 2020$28.20M+228.7%
Q1 FY2020Mar 31, 2020$32.07M+182.8%
Q4 FY2019Dec 31, 2019$23.67M+32.1%
Q3 FY2019Sep 30, 2019$6.01M-74.0%
Q2 FY2019Jun 30, 2019$8.58M-71.6%
Q1 FY2019Mar 31, 2019$11.34M+31.6%
Q4 FY2018Dec 31, 2018$17.92M+260.0%
Q3 FY2018Sep 30, 2018$23.14M+162.8%
Q2 FY2018Jun 30, 2018$30.20M+87.6%
Q1 FY2018Mar 31, 2018$8.62M-48.0%
Q4 FY2017Dec 31, 2017$4.98M-78.6%
Q3 FY2017Sep 30, 2017$8.80M-68.7%
Q2 FY2017Jun 30, 2017$16.10M–
Q1 FY2017Mar 31, 2017$16.55M–
Q4 FY2016Dec 31, 2016$23.23M–
Q3 FY2016Sep 30, 2016$28.09M–

More Traws Pharma figures

See a number that looks wrong?